Table III.

Detailed characteristics of our myeloproliferative neoplasms patients with precapillary pulmonary hypertension

No.	Age, gender	Type of MPN	Disease duration	ECHO derived sPAP	ECG	NT-proBNP [pg/ml]	VEGF [pg/ml]	Type of PH	RHC	Specific treatment for PH	Survival after PH diagnosis
1	68 years, female	ET	5 years	90 mm Hg	Sinus rhythm RBBB	5910	889	Precapillary (Group 5)	Mean PAP: 63 mm Hg PAWP: 8 mm Hg CO: 2.2 l/min PVR: 25 Wood	Tadalafil, macitentan	28 months, living
2	71 years, male	PV	9 years	71 mm Hg	Sinus rhythm RBBB	7847	138	CTEPH	Refused	Refused	6 months, deceased

sPAP – systolic pulmonary artery pressure, RHC – right heart catheterization, PH – pulmonary hypertension, ET – essential thrombocythemia, PV – polycythemia vera, HU – hydroxyurea, RBBB – right bundle branch block, CTEPH – chronic thromboembolic pulmonary hypertension, PAWP – pulmonary artery wedge pressure, CO – cardiac output, PVR – pulmonary vascular resistance.